Oncolytics Biotech Inc. (ONCY)
NASDAQ: ONCY · Real-Time Price · USD
0.831
-0.056 (-6.36%)
At close: Dec 20, 2024, 4:00 PM
0.830
-0.001 (-0.12%)
After-hours: Dec 20, 2024, 6:45 PM EST
Oncolytics Biotech Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 19.6 | 34.91 | 11.67 | 41.26 | 31.22 | 14.15 | Upgrade
|
| Short-Term Investments | - | - | 20.47 | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 19.6 | 34.91 | 32.14 | 41.26 | 31.22 | 14.15 | Upgrade
|
| Cash Growth | -50.98% | 8.63% | -22.11% | 32.17% | 120.66% | 3.27% | Upgrade
|
| Other Receivables | 0.1 | 0.02 | 0.03 | 0.08 | 0.09 | 0.57 | Upgrade
|
| Receivables | 0.1 | 0.02 | 0.03 | 0.08 | 0.09 | 0.57 | Upgrade
|
| Prepaid Expenses | 2.12 | 1.93 | 1.7 | 2.78 | 2.43 | 2.71 | Upgrade
|
| Other Current Assets | 1.09 | 1.32 | 1.82 | 0.78 | - | 1.5 | Upgrade
|
| Total Current Assets | 22.91 | 38.17 | 35.68 | 44.9 | 33.74 | 18.93 | Upgrade
|
| Property, Plant & Equipment | 1.35 | 0.65 | 0.65 | 0.98 | 0.61 | 0.73 | Upgrade
|
| Other Long-Term Assets | - | - | 1 | - | - | - | Upgrade
|
| Total Assets | 24.26 | 38.82 | 37.33 | 45.88 | 34.35 | 19.66 | Upgrade
|
| Accounts Payable | 3.43 | 1.08 | 2.25 | 0.59 | 1.81 | 3.17 | Upgrade
|
| Accrued Expenses | 3.5 | 2.49 | 1.4 | 1.39 | - | - | Upgrade
|
| Current Portion of Leases | 0.25 | 0.13 | 0.22 | 0.29 | 0.25 | 0.34 | Upgrade
|
| Other Current Liabilities | 0.49 | 0.53 | 0.08 | 0.41 | 0.66 | 9.36 | Upgrade
|
| Total Current Liabilities | 7.66 | 4.24 | 3.95 | 2.69 | 2.71 | 12.87 | Upgrade
|
| Long-Term Leases | 0.81 | 0.29 | 0.16 | 0.36 | 0.15 | 0.17 | Upgrade
|
| Long-Term Unearned Revenue | 6.73 | 6.73 | 6.73 | 6.73 | 6.73 | 6.73 | Upgrade
|
| Total Liabilities | 15.21 | 11.26 | 10.83 | 9.78 | 9.59 | 19.77 | Upgrade
|
| Common Stock | 434.46 | 430.91 | 404.04 | 391.35 | 356.82 | 311.08 | Upgrade
|
| Additional Paid-In Capital | 43.64 | 42.12 | 40.05 | 34.16 | 31.02 | 29.34 | Upgrade
|
| Retained Earnings | -469.7 | -446 | -418.25 | -393.42 | -367.11 | -344.61 | Upgrade
|
| Comprehensive Income & Other | 0.65 | 0.54 | 0.66 | 4.01 | 4.02 | 4.08 | Upgrade
|
| Shareholders' Equity | 9.06 | 27.56 | 26.5 | 36.1 | 24.75 | -0.11 | Upgrade
|
| Total Liabilities & Equity | 24.26 | 38.82 | 37.33 | 45.88 | 34.35 | 19.66 | Upgrade
|
| Total Debt | 1.06 | 0.42 | 0.37 | 0.66 | 0.4 | 0.51 | Upgrade
|
| Net Cash (Debt) | 18.53 | 34.49 | 31.77 | 40.61 | 30.82 | 13.64 | Upgrade
|
| Net Cash Growth | -53.04% | 8.58% | -21.77% | 31.77% | 125.91% | -0.42% | Upgrade
|
| Net Cash Per Share | 0.25 | 0.51 | 0.55 | 0.76 | 0.76 | 0.62 | Upgrade
|
| Filing Date Shares Outstanding | 77.07 | 75.42 | 62.83 | 57.11 | 52.08 | 37.38 | Upgrade
|
| Total Common Shares Outstanding | 77.07 | 74.42 | 61.33 | 55.04 | 46.17 | 32.2 | Upgrade
|
| Working Capital | 15.25 | 33.94 | 31.74 | 42.21 | 31.03 | 6.06 | Upgrade
|
| Book Value Per Share | 0.12 | 0.37 | 0.43 | 0.66 | 0.54 | -0.00 | Upgrade
|
| Tangible Book Value | 9.06 | 27.56 | 26.5 | 36.1 | 24.75 | -0.11 | Upgrade
|
| Tangible Book Value Per Share | 0.12 | 0.37 | 0.43 | 0.66 | 0.54 | -0.00 | Upgrade
|
| Machinery | - | 0.75 | 0.74 | 0.69 | 0.78 | 0.77 | Upgrade
|
| Leasehold Improvements | - | 0.23 | 0.23 | 0.23 | 0.5 | 0.5 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.